Zentalis Pharmaceuticals (ZNTL) PT Lowered to $28 at UBS
Tweet
Share
E-mailGet Alerts ZNTL Hot Sheet
Price: $3.56 -14.22%
Rating Summary:
8 Buy, 6 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
8 Buy, 6 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
UBS analyst Eliana Merle lowered the price target on Zentalis Pharmaceuticals (NASDAQ: ZNTL) to $28.00 (from $52.00) while maintaining a Buy rating.
You May Also Be Interested In
- Zentalis Pharmaceuticals prices $80.5M public stock offering
- Zentalis Pharmaceuticals Announces Pricing of Underwritten Public Offering
- Honasa Consumer Ltd (HONASA:IN) PT Raised to INR720 at ICICI Securities
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
